Heart Failure; With Decompensation
Conditions
Keywords
heart failure, cardial decompensation, smart scale, bioimpedance analysis, whole body water
Brief summary
In this trial the measurement of whole body water will be compared to the standard method of measuring the body weight as treatment guidance in patients with decompensated heart failure. The Seca mBCA 515 \[medical Body Composition Analyser\] will be used to quantify the whole body water by using bioelectrical impedance analysis.
Detailed description
Investigators will include 153 participants hospitalized in the University Hospital in Basel. Daily measurements of whole body water and body weight will be performed in each person until diuretic treatment is stopped or the patient is discharged from hospital, respectively. Primary endpoint is the correlation between reduction of whole body water (in kg) and reduction of body weight (in kg) in patients with decompensated heart failure receiving forced diuretic treatment (max. deviation +/- 1kg).
Interventions
DEVICESeca medical Body Composition Analyser 515
Comparison of reduction of whole body water and body weight in patients with decompensated heart failure under forced diuretic treatment
Sponsors
University Hospital, Basel, Switzerland
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* able to give informed consent * hospitalization because of decompensated heart failure treated with forced diuresis * able to stand on the scale without help from others and able to hold handrails with both hands
Exclusion criteria
* refusal to share personal data * implantable electronic device (e.g. Pacemaker, etc.) * condition that does not allow skin contact of soles of feet and scale or hands with handrail (leg prosthesis, wounds, bandage, etc.)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of total body water (TBW) in kg | From baseline until the date of hospital discharge or stop date of forced diuretic treatment, whichever came first, assessed up to 2 weeks. | total body water (TBW) in kg will be measured daily |
| Measurement of body weight (BW) in kg | From baseline until the date of hospital discharge or stop date of forced diuretic treatment, whichever came first, assessed up to 2 weeks. | body weight (BW) in kg will be measured daily |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of fatty tissue (FT) in kg | From baseline until the date of hospital discharge or stop date of forced diuretic treatment, whichever came first, assessed up to 2 weeks. | To provide a more exact comparison of total body water and body weight, fatty mass will be subtracted from the body weight. Subsequently the absolute difference between the reduction of the total body water (in kg) and the reduction of the body weight (in kg), in which fatty tissue (in kg) was subtracted, will be calculated (e.g. (BW day 1- FT day 1) - (BW day 2 - FT day 2) = reduction of BW without fatty tissue). |
Countries
Switzerland
Outcome results
None listed